Editor(s):
(1) Dr. Takashi Ikeno, National Cancer Center Hospital East, Clinical Research Support Office, Japan.
(2) Dr. Asmaa Fathi Moustafa Hamouda, Assistant Professor, Jazan University, Saudi Arabia.
Reviewers:
(1) Mohammad Yusuf Alamudi, Mohammad Raihan Alamudi Institute, Indonesia.
(2) Maria Cristina Gonzalez Torres, Universidad Autónoma Metropolitana, Mexico.
(3) Zahraa Kamaz, Iraq.
(4) Qusay Kh. Al-Dulamey, Mosul University, Iraq.
(5) Sahar Mohamed Mahdy Omar, Ain Shams & Galala University, Egypt.
(6) Erika Palomares Resendiz, INIFAP, Mexico.
Additional Reviewers:
(1) Bom B. C., Rapti Academy of Health Sciences, Nepal.
(2) Christulas Jyoti, TATA Main Hospital, India.
(3) José López Castro, Spain.
(4) Leonardo Gilardi, Argentina.
(5) Riswani Tanjung, Sumatera Utara University, Indonesian.
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 8/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer review report_1 (Mohammad Yusuf Alamudi, Indonesia) | File 1 | File 2
Stage 2 | Peer review report_2 (Maria Cristina Gonzalez Torres, Mexico) | File 1 | NA
Stage 2 | Peer review report_3 (Zahraa Kamaz, Iraq) | File 1 | NA
Stage 2 | Peer review report_4 (Qusay Kh. Al-Dulamey, Iraq) | File 1 | NA
Stage 2 | Peer review report_5 (Sahar Mohamed Mahdy Omar, Egypt) | File 1 | NA
Stage 2 | Peer review report_6 (Erika Palomares Resendiz, Mexico) | File 1 | NA
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA
Stage 3 | Comment_Editor_2_v1 | File 1 | NA
Stage 3 | Revised_MS_v2_and_Feedback_v2 | File 1 | NA